Related Experiment Video

Updated: Jun 27, 2025

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization
07:41

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization

Published on: August 4, 2023

3.3K

Current treatment strategies for targeting virulence factors and biofilm formation in Acinetobacter baumannii

Seetha Lakshmi Rajangam1, Manoj Kumar Narasimhan1

  • 1Department of Genetic Engineering, School of Bioengineering, College of Engineering & Technology, SRM Institute of Science & Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.

Future Microbiology
|April 29, 2024
PubMed

Insights

Acinetobacter baumannii infections are increasing in hospitals, especially those linked to devices. This review explores biofilm formation and new treatments to combat these dangerous infections and improve patient outcomes.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Rising prevalence of Acinetobacter baumannii infections and mortality in hospital-acquired infections (HAI).
  • Acinetobacter baumannii's biofilm formation enhances its virulence and antibiotic resistance, particularly in device-associated HAIs (DA-HAI).
  • Exacerbated SARS-CoV-2 transmission in DA-HAI during the recent epidemic.

Purpose of the Study:

  • To examine the intricate relationship between genes, biofilm formation, and infection development in Acinetobacter baumannii.
  • To provide insights into novel therapeutic strategies against Acinetobacter baumannii biofilm infections.
  • To improve patient outcomes and reduce the overall burden of HAI.

Main Methods:

  • Literature review focusing on genetic components and molecular mechanisms of Acinetobacter baumannii biofilm formation.
  • Analysis of current and emerging therapeutic approaches for combating Acinetobacter baumannii infections.
  • Synthesis of information on the impact of DA-HAI on infection transmission.

Main Results:

  • Identification of key genes and components crucial for Acinetobacter baumannii biofilm development.
  • Highlighting the challenges posed by antibiotic resistance in biofilm-related infections.
  • Underscoring the link between DA-HAI and increased pathogen transmission, including SARS-CoV-2.

Conclusions:

  • Understanding the molecular basis of biofilm formation is critical for developing effective treatments.
  • Innovative therapeutic strategies are needed to overcome antibiotic resistance in Acinetobacter baumannii infections.
  • Targeting biofilm formation presents a promising avenue for reducing HAI and improving patient prognoses.
Keywords:
Acinetobacter baumanniibacteriophagebiofilmdevice-associated infectionquorum sensing inhibitorssiderophores

More Related Videos

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases07:47

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Published on: January 1, 2016

11.5K
Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

588

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
323